Treatment of neurodegenerative diseases by targeting miRNA

Treatment of neurodegenerative diseases by targeting miRNA

  • CN 103,189,069 A
  • Filed: 09/09/2011
  • Published: 07/03/2013
  • Est. Priority Date: 09/13/2010
  • Status: Active Grant
First Claim
Patent Images

1. the prevention of a neurodegenerative diseases or medicine for treatment agent compositions is characterized in that, comprise:

  • (a) has the pharmaceutics effective dose of antisense oligonucleotide of the sequence of second nucleotide sequence to the, the seven nucleotide sequence complementations in the nucleotide sequence with sequence table first sequence;

    And(b) receptible carrier on the pharmaceutics.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×